Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/25331| Title: | First-Line Durvalumab plus Tremelimumab vs Platinum-Based Chemotherapy for Advanced/Metastatic NSCLC: Phase 3 NEPTUNE Study |
| Authors: | MOK, Tony; SCHMID, Peter; CASTRO JR., Gilberto De; SYRIGOS, Kostas; MARTIN, Claudio; YAMAMOTO, Nobuyuki; AREN, Osvaldo; ARRIETA, Oscar; GOTTFRIED, Maya; JAZIEH, Abdul Rahman; RAMLAU, Rodryg; TIMCHEVA, Constanta; TRANI, Leonardo |
| Citation: | JOURNAL OF THORACIC ONCOLOGY, v.12, n.1, suppl.S, p.S1084-S1084, 2017 |
| Appears in Collections: | Comunicações em Eventos - HC/ICESP Comunicações em Eventos - LIM/24 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.